E11.339 Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

Name of the Condition

• Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema

Summary

Type 2 diabetes mellitus with moderate nonproliferative diabetic retinopathy without macular edema is a condition where chronic high blood sugar levels cause damage to the small blood vessels in the retina, leading to moderate retinal changes without swelling in the macula. This stage is characterized by increased microaneurysms, dot-blot hemorrhages, hard exudates, and venous beading, but no significant macular edema. While vision may not be immediately affected, ongoing monitoring is essential to prevent progression to more severe stages.

Causes

High blood sugar levels over time damage the retinal blood vessels, leading to moderate nonproliferative diabetic retinopathy. Insulin resistance or insufficient insulin production in type 2 diabetes contributes to sustained hyperglycemia, which triggers vascular changes in the retina. Metabolic factors associated with diabetes, such as advanced glycation end products, also play a role in this ocular complication.

Risk Factors

• Poorly controlled blood glucose levels.
• Long duration of diabetes.
• Hypertension and dyslipidemia.
• Smoking.
• Obesity and sedentary lifestyle.

Symptoms

• Mild to moderate blurring or fluctuating vision.
• Presence of floaters or spots in the visual field.
• Difficulty with night vision.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated retinal imaging (e.g., fundus photography or optical coherence tomography) to assess retinal changes. Blood tests to evaluate glycemic control and other metabolic markers may also be performed. The absence of macular edema is confirmed through clinical evaluation and imaging.

Treatment Options

Management focuses on optimizing blood glucose, blood pressure, and lipid levels to slow disease progression. Regular eye exams are recommended to monitor for changes. In some cases, laser therapy or anti-VEGF injections may be considered if retinopathy advances, though these are not typically needed for moderate nonproliferative disease without macular edema.

Prognosis and Follow-Up

With proper glycemic control and regular monitoring, progression to severe retinopathy can be delayed. Follow-up eye exams are typically scheduled every 6 to 12 months, or more frequently if changes occur. Early intervention is key to preserving vision.

Complications

If left unmanaged, moderate nonproliferative diabetic retinopathy may progress to severe nonproliferative or proliferative diabetic retinopathy, increasing the risk of vision loss. Macular edema may also develop over time, further threatening central vision.

Lifestyle & Prevention

• Maintain tight blood glucose control through diet, exercise, and medication.
• Manage blood pressure and cholesterol levels.
• Avoid smoking and limit alcohol intake.
• Engage in regular physical activity and maintain a healthy weight.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or vision loss. Regular eye exams are critical for early detection and management of retinopathy.

Tips for Medical Coders

Document the absence of macular edema clearly in the medical record, as this distinguishes E11.339 from codes with macular edema. Ensure clinical documentation supports the moderate nonproliferative stage, including retinal findings such as microaneurysms, hemorrhages, exudates, or venous beading. Code E11.339 is specific to type 2 diabetes with moderate nonproliferative retinopathy and no macular edema.